Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT00076011 · COMPLETED

Trial details

NCT number: NCT00076011
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2003-10-01
Primary completion: 2007-02-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.